Objective: To prepare and calibrate the new batch of national standard material of prostate specific antigen (PSA)for immunoassay. Methods: PSA international standard material from National Institute for Biological Standards and Control(NIBSC)was used for value transfer,and eight kinds of kits included in three mechanisms, CLIA,ELISA and TRFIA were used for joint calibration. In addition,the homogeneity and stability were evaluated, the quantification uncertainty was analyzed and estimated at the same time. Results: The quantitawve value of the national standard material in this batch of PSA was 190 ng·mL-1,and the uncertainty was ±27 ng·mL-1. Precision between bottles was 0.98%. Stability test showed that it was stable after storage at 4℃ for 11 weeks with t-test straight slop < t0.95,6*S(b1),but unstable after storage at 37℃ for 11 weeks with t-test straight slop > t0.95,6*S (b1)。The results showed that the PSA in the sample was significantly degraded while the concentration of fPSA significantly increased Conclusion: The quantification process of this new batch of PSA national standard material is reasonable with good homogeneity and stability. It can meet the need of product research and quality evaluation of PSA kits. PSA national standard material is unstable when it was stored at an elevated temperature,so cold chain should be applied to its transportation.
[1] 王莉,赵娅南,李志燕. TPSA、FPSA、FPSA/TPSA 和Ferr 检测 对于前列腺癌的诊断价值[J]. 标记免疫分析与临床,2014,21 (2):160 WANG L,ZHAO YN,LI ZY. Diagnostic value of TPSA,FPSA, FPSA/TPSA and Ferritin for prostate cancer[J]. Labeled Immunoassay Clin Med,2014,21(2):160
[2] 杨宗珂,王德林,杨研,等. 前列腺特异性抗原及其相关指标在 前列腺癌鉴别诊断中的应用价值[J]. 中国医学装备,2015,12 (12):31 YANG ZK,WANG DL,YANG Y,et al. Research on clinical application value of prostate specific antigen indexes in the differential diagnosis of benign prostatic hyperplasia and prostate cancer[J]. China Med Equip,2015,12(12):31
[3] 戴波,瞿元元,孔蕴毅,等. PSA 倍增时间对去势抵抗性前列腺癌 患者多西他赛化疗后总生存期的影响[J]. 临床泌尿外科杂志, 2013,28(2):113 DAI B,ZHAI YY,KONG YY,et al. Prognostic value of prostatespecific antigen doubling time for patients with metastatic castrationresistant prostate cancer treated with docetaxel-based chemotherapy[J]. J Clin Urol,2013,28(2):113
[4] ALBERTS AR,SCHOOTS IG,ROOBOL MJ. Prostate-specific antigen-based prostate cancer screening:past and future[J]. Int J Urol,2015 Apr 6. doi:10. 1111/iju. 12750[Epub ahead of print]
[5] MILKOVIC B,DZAMIC Z,PEJCIC T,et al. Evaluation free-to-total prostate specific antigen(F/T PSA),prostate specific antigen density (PSAD)and(F/T)/PSAD sensitivity on reduction of unnecessary prostate biopsies for patients with PSA in gray zone[J]. Ann Ital Chir,2014,85(5):448-453.
[6] 王玉梅,刘艳,孙楠,等. 免疫测定用甲胎蛋白国家标准品的制备 与定值[J]. 中国药事,2014,28(8):843 WANG YM,LIU Y,SUN N,et al. Preparation and calibration of national standard material of alpha fetoprotein for immunoassay[J]. Chin Pharm Aff,2014,28(8):843
[7] 全国标准物质管理委员会编著. 标准物质定值原则和统计学原 理[M]. 北京:中国质检出版社,2011:84 National Standard Material Management Committee. Fixed Value and Statistical Principles of The Standard Substance[M]. Beijing: China Zhijian Publishing House,2011:84
[8] WHO International Standard Prostate Specific Antigen(90: 10)NIBSC code:96/670 Instructions for use(Version 5.0,Date 30/11/2011)[EB/OL]. [2016-1-18]. http://www.nibsc.org/documents/ifu/96-670.pdf
[9] SALMAN JW,SCHOOTS IG,CARLSSON SV,et al. Prostate specific antigen as a tumor marker in prostate cancer:biochemical and clinical aspects[J]. Adv Exp Med Biol,2015,867:93. doi: 10.1007/978-94-017-7215-0_7
[10] 全国标准物质管理委员会编著. 标准物质的研制管理与应用[M]. 北京:中国计量出版社,2010:13 National Standard Material Management Committee. Development Management and Application of Reference Materials[M]. Beijing: China Metrology Publishing House,2010:13
[11] 魏霞. 正确使用标准物质/标准样品[J]. 化学分析计量,2014, 23(3):85 WEI X. Proper use of reference material[J]. Chem Anal Meterage, 2014,23(3):85
[12] GB/T 21415-2008/ISO 17511:2003 体外诊断医疗器械生物样品 中量的测量校准品和控制物质赋值的计量学溯源性[S]. 2008 GB/T 21415-2008/ISO 17511:2003 In Vitro Diagnostic Medical Devices—Measurement of Quantities in Biological Samples— Metrological Traceability of Values Assigned to Calibrators and Control Materials[S]. 2008
[13] 杨振,黄杰,于婷,等. 我国体外诊断试剂国家标准物质现状及对 策分析[J]. 中国生物制品学杂志,2015,28(7):765 YANG Z,HUANG J,YU T,et al. Present situation and the countermeasure analysis of national IVD standard substances in China[J]. Chin J Biol,2015,28(7):765
[14] 刘艳,孙楠,王玉梅,等. 体外诊断试剂行业标准制定工作的现状 分析及展望[J]. 中国医疗器械杂志,2014,38(6):383 LIU Y,SUN N,WANG YM,et al. Situation and suggestions on IVD industrial standards[J]. Chin J Med Instrum,2014,38(6):383
[15] YY/T 1163-2009 总前列腺特异性抗原(t-PSA)定量测定试剂 (盒)(化学发光免疫分析法)[S]. 2009 YY/T 1163-2009 Total Prostate Specific Antigen(t-PSA) Quantitative Detection Reagent(Kit)(Chemiluminescent Immunoassay)[S]. 2009